Literature DB >> 2589005

Interleukin 1 and 2 production by peripheral blood mononuclear cells in subacute sclerosing panencephalitis and exacerbation of multiple sclerosis.

W Brajczewska-Fischer1, B Iwińska, J Kruszewska, J Korlak, A Członkowska.   

Abstract

Il-1 and Il-2 production by peripheral blood mononuclear cells was studied in 10 patients with SSPE and 15 patients in the acute stage of MS. Both SSPE and MS cells in vitro released spontaneously high amounts of Il-1, and could not be further stimulated to synthesis of Il-1 by latex. The Il-2 production was decreased in both processes but in MS after the recovery from the acute stage the production of Il-2 increased. The role of the observed changes in both Il-1 and Il-2 secretion in the pathogenesis of SSPE and MS is unknown.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2589005     DOI: 10.1111/j.1600-0404.1989.tb03899.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  5 in total

1.  CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis.

Authors:  A D Crockard; M T Treacy; A G Droogan; S A Hawkins
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

2.  Correlation of -475 IL-2 Promoter Gene Polymorphisms and the Levels of Serum IL-2 on the Risk of Multiple Sclerosis.

Authors:  Thekra Abdulaali Abed; Anwar Ali Abdulla
Journal:  Rep Biochem Mol Biol       Date:  2022-04

3.  Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Vuslat Yilmaz; Veysi Demirbilek; Candan Gürses; Sibel P Yentür; Serap Uysal; Zuhal Yapici; Gülden Yilmaz; Aaron Muncey; Ozlem Cokar; Emel Onal; Aysen Gökyiğit; Güher Saruhan-Direskeneli
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

4.  Prolonged dynamic clinico-immunological observation of 85 patients with definite multiple sclerosis: first steps towards monitoring process activity.

Authors:  E I Gusev; T L Demina; A N Boiko; B V Pinegin
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

Review 5.  Autoimmune disease and the nervous system. Biochemical, molecular, and clinical update.

Authors:  J E Merrill; M C Graves; D G Mulder
Journal:  West J Med       Date:  1992-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.